A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma

Completed · Phase 2

Conditions studied: Pancreatic Adenocarcinoma

In brief

Determine the relapse-free survival of resected pancreatic cancer patients following two novel regimens with activity in advanced disease.

Key facts

Study ID
NCT01839799
Run by
Abramson Cancer Center at Penn Medicine
People needed
32
Starts
2013-04-01
Expected to finish
2017-07-01
Last updated by the study team
2021-02-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.